Funding for this research was provided by:
King's College London
Text and Data Mining valid from 2018-11-15
First Online: 15 November 2018
Change Date: 27 November 2019
Change Type: Correction
Change Details: Under the heading <b><i>BAT in the Follow-up of Patients Submitted to Allergen-Specific Immunotherapy and Other Immunomodulatory Treatments</i></b><i>,</i> the second sentence in the paragraph should read as follows:
Compliance with Ethical Standards
: Dr. Santos reports grants from Medical Research Council, NIAID/Immune Tolerance Network, Asthma UK; personal fees from Thermo Scientific, Nutricia, InfoMed and Buhlmann other from National Institute of Health (NIH) and National Institute for Health Research (NIHR), European Academy of Allergy and Clinical Immunology (EAACI), British Society of Allergy and Clinical Immunology (BSACI), Academy of Medical Sciences, Portuguese Society of Allergy and Clinical Immunology (SPAIC), Spanish Society of Allergy and Clinical Immunology (SEAIC), French Meeting of Molecular Allergology, Swiss Society of Allergology and Clinical Immunology and French Society of Immunology, outside the submitted work. The other authors declare no conflicts of interest relevant to this manuscript.
: This article does not contain any studies with human or animal subjects performed by any of the authors.